...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >A chemo-enzymatic expeditious route to racemic dihexanoyl (2R*,3R*,4R*)-dehydroxymethylepoxyquinomycin (DHMEQ), the precursor for lipase-catalyzed synthesis of the potent nuclear factor-κB inhibitor, (2 S,3S,4 S)-DHMEQ
【24h】

A chemo-enzymatic expeditious route to racemic dihexanoyl (2R*,3R*,4R*)-dehydroxymethylepoxyquinomycin (DHMEQ), the precursor for lipase-catalyzed synthesis of the potent nuclear factor-κB inhibitor, (2 S,3S,4 S)-DHMEQ

机译:化学酶促快速途径生成外消旋二己酰基(2R *,3R *,4R *)-脱羟甲基环氧丁香霉素(DHMEQ)(脂肪酶催化的有效核因子-κB抑制剂的合成前体)(2 S,3S,4 S) -DHMEQ

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In order to synthesize the potent nuclear factor (NF)- κB inhibitor, (2S,3 S,4 S)-dehydroxymethylepoxyquinomycin (DHMEQ), in a large scale, a new route for its corresponding racemic precursor, dihexanoyl (2R*,3R*, 4R*)- DHMEQ, was developed. By employing both hydroquinone and benzoquinone intermediates, the total yield, reproducibility, and synthetic steps were improved and the synthetic cost was reduced.
机译:为了大规模合成有效的核因子(NF)-κB抑制剂(2S,3 S,4 S)-脱羟甲基环氧丁香霉素(DHMEQ),其相应外消旋前体二己酰基(2R *,3R)的新途径*,4R *)-DHMEQ已开发。通过同时使用氢醌和苯醌中间体,可提高总收率,可重复性和合成步骤,并降低合成成本。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号